Time-kill curves for a semisynthetic glycopeptide, LY333328, against vancomycin-susceptible and vancomycin-resistant Enterococcus faecium strains.

समान संसाधन

• Synergy of an Investigational Glycopeptide, LY333328, with Once-Daily Gentamicin against Vancomycin-Resistant Enterococcus faecium in a Multiple-Dose, In Vitro Pharmacodynamic Model
  द्वारा: Zelenitsky, S. A., और अन्य
  प्रकाशित: (1999)
• In vitro kill curves of a new semisynthetic echinocandin, LY-303366, against fluconazole-sensitive and -resistant Candida species.
  द्वारा: Karlowsky, J A, और अन्य
  प्रकाशित: (1997)
• In vitro antibacterial activity of LY333328, a new semisynthetic glycopeptide.
  द्वारा: Biavasco, F, और अन्य
  प्रकाशित: (1997)
• Pharmacodynamic evaluation of a new glycopeptide, LY333328, and in vitro activity against Staphylococcus aureus and Enterococcus faecium.
  द्वारा: Mercier, R C, और अन्य
  प्रकाशित: (1997)
• Influence of Human Serum on Pharmacodynamic Properties of an Investigational Glycopeptide, LY333328, and Comparator Agents against Staphylococcus aureus
  द्वारा: Zhanel, George G., और अन्य
  प्रकाशित: (1998)